Neuren Pharma tumbles 14pc on short-seller report
NEW YORK: Neuren Pharmaceuticals has rebuked a short seller report targeting its US-listed ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
